rs1009229752

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_033395.2(CEP295):​c.548T>A​(p.Ile183Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000333 in 1,500,236 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000026 ( 0 hom., cov: 33)
Exomes 𝑓: 7.4e-7 ( 0 hom. )

Consequence

CEP295
NM_033395.2 missense

Scores

2
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.198

Publications

0 publications found
Variant links:
Genes affected
CEP295 (HGNC:29366): (centrosomal protein 295) Enables microtubule binding activity. Involved in several processes, including centriole replication; positive regulation of protein acetylation; and regulation of centrosome duplication. Located in cytosol; microtubule cytoskeleton; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.21783423).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CEP295NM_033395.2 linkc.548T>A p.Ile183Asn missense_variant Exon 6 of 30 ENST00000325212.11 NP_203753.1 Q9C0D2-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CEP295ENST00000325212.11 linkc.548T>A p.Ile183Asn missense_variant Exon 6 of 30 2 NM_033395.2 ENSP00000316681.6 Q9C0D2-1

Frequencies

GnomAD3 genomes
AF:
0.0000263
AC:
4
AN:
152124
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00000870
AC:
1
AN:
114912
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.000182
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
7.42e-7
AC:
1
AN:
1348112
Hom.:
0
Cov.:
26
AF XY:
0.00
AC XY:
0
AN XY:
665168
show subpopulations
African (AFR)
AF:
0.0000351
AC:
1
AN:
28478
American (AMR)
AF:
0.00
AC:
0
AN:
23308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24002
East Asian (EAS)
AF:
0.00
AC:
0
AN:
32714
South Asian (SAS)
AF:
0.00
AC:
0
AN:
70672
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48892
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5590
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1058590
Other (OTH)
AF:
0.00
AC:
0
AN:
55866
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000263
AC:
4
AN:
152124
Hom.:
0
Cov.:
33
AF XY:
0.0000269
AC XY:
2
AN XY:
74318
show subpopulations
African (AFR)
AF:
0.0000965
AC:
4
AN:
41450
American (AMR)
AF:
0.00
AC:
0
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5206
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67950
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000227

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Nov 01, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.548T>A (p.I183N) alteration is located in exon 6 (coding exon 5) of the CEP295 gene. This alteration results from a T to A substitution at nucleotide position 548, causing the isoleucine (I) at amino acid position 183 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
16
DANN
Uncertain
0.98
DEOGEN2
Benign
0.032
T
Eigen
Benign
-0.39
Eigen_PC
Benign
-0.52
FATHMM_MKL
Benign
0.088
N
LIST_S2
Benign
0.80
T
M_CAP
Benign
0.069
D
MetaRNN
Benign
0.22
T
MetaSVM
Benign
-1.0
T
PhyloP100
-0.20
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-1.9
N
REVEL
Benign
0.048
Sift
Uncertain
0.0050
D
Sift4G
Benign
0.22
T
Polyphen
0.90
P
Vest4
0.50
MVP
0.081
MPC
0.19
ClinPred
0.15
T
GERP RS
0.50
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.15
gMVP
0.13
Mutation Taster
=237/63
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1009229752; hg19: chr11-93408756; API